Drug Shortage Report for JAMP IMATINIB
Report ID | 183671 |
Drug Identification Number | 02495066 |
Brand name | JAMP IMATINIB |
Common or Proper name | Imatinib mesylate |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | IMATINIB |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 12x10 |
ATC code | L01EA |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-02-06 |
Estimated end date | 2025-12-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-02-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2024-02-19 | French | Compare |
v10 | 2024-02-19 | English | Compare |
v9 | 2023-05-02 | French | Compare |
v8 | 2023-05-02 | English | Compare |
v7 | 2023-04-12 | French | Compare |
v6 | 2023-04-12 | English | Compare |
v5 | 2023-03-11 | French | Compare |
v4 | 2023-03-11 | English | Compare |
v3 | 2023-02-07 | English | Compare |
v2 | 2023-02-06 | French | Compare |
v1 | 2023-02-06 | English | Compare |
Showing 1 to 11 of 11